Edenwell Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.15 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 177.22%
- Profit Growth 238.89%
- Ebitda 385.48%
- Net Worth 107.62%
- Total Assets 43.85%
About Edenwell Therapeutics
Edenwell Therapeutics Private Limited (ETPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 June 2017 (Seven years and ten months 22 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Parvez Kosgi, Kamlesh Londhe, and Shoeb Kosgi serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85320MH2017PTC296318
- Company No.
296318
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jun 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
What products or services does Edenwell Therapeutics Private Limited offer?
Edenwell Therapeutics Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Computer, IT & Software Training, Computer Language Training Services, ISO & Quality Management Consultants, Certification Services, Data Entry & Data Processing Service, Data Management, Company Law & Labour Law Consultants, Statutory Compliance Services.
Edenwell Therapeutics Private Limited
Explore comprehensive data for Edenwell Therapeutics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Edenwell Therapeutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parvez Kosgi  | Director | 19-Jun-2017 | Current |
| Kamlesh Londhe | Director | 19-Jun-2017 | Current |
| Shoeb Kosgi | Director | 21-Nov-2018 | Current |
Financial Performance of Edenwell Therapeutics.
Edenwell Therapeutics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 177.22% increase. The company also saw a substantial improvement in profitability, with a 238.89% increase in profit. The company's net worth Soared by an impressive increase of 107.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Edenwell Therapeutics?
In 2020, Edenwell Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biznexus Exim LlpParvez Kosgi is a mutual person
- Wellshield Health Llp
Parvez Kosgi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Edenwell Therapeutics?
Unlock and access historical data on people associated with Edenwell Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Edenwell Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edenwell Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Edenwell Therapeutics
Recent activity within the organization
- Annual General Meeting
Edenwell Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Edenwell Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Shoeb Mohammed Kosgi was appointed as a Director was appointed as a Director on 21 Nov 2018 & has been associated with this company since 6 years 5 months .
- Director Appointment
Parvez Ahmed Abdulgaffar Kosgi was appointed as a Director was appointed as a Director on 19 Jun 2017 & has been associated with this company since 7 years 10 months .
- Director Appointment
Kamlesh Bajirao Londhe was appointed as a Director was appointed as a Director on 19 Jun 2017 & has been associated with this company since 7 years 10 months .
- Company Incorporation
Edenwell Therapeutics Private Limited was registered on 19 Jun 2017 with Roc Mumbai & aged 7 years 10 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Edenwell Therapeutics Private Limited?
Edenwell Therapeutics Private Limited was incorporated on 19 Jun 2017.
What is authorized share capital and paid-up capital of Edenwell Therapeutics Private Limited?
The authorized share capital of Edenwell Therapeutics Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.15 M.
Who are the current board members & directors of Edenwell Therapeutics Private Limited?
Currently 3 directors are associated with Edenwell Therapeutics Private Limited.
- Parvez Ahmed Abdulgaffar Kosgi
- Kamlesh Bajirao Londhe
- Shoeb Mohammed Kosgi
What is the registered address of Edenwell Therapeutics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Edenwell Therapeutics Private Limited is 2003 W-26 Casa Celeste-L Lodha Amara Clariant Compound Kolshet Road W Est, India, Thane, Maharashtra, 400607.
What is the corporate identification number (CIN) and company number of Edenwell Therapeutics Private Limited?
The corporate identification number (CIN) of Edenwell Therapeutics Private Limited is U85320MH2017PTC296318 and the company number is 296318 as per Ministry of Corporate Affairs (MCA).
What is the official website of Edenwell Therapeutics Private Limited?
The Official website of Edenwell Therapeutics Private Limited is https://www.edenwelltherapeutics.com
What has been the recent revenue trend for Edenwell Therapeutics Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Edenwell Therapeutics Private Limited has risen by 177.22%.
What change has been observed in the net worth of Edenwell Therapeutics Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Edenwell Therapeutics Private Limited has experienced an upsurge of 107.62%.
When was the last Balance Sheet of Edenwell Therapeutics Private Limited filed with the ROC?
The most recent Balance Sheet for Edenwell Therapeutics Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records